Anokion SA operates as a biotechnology company that develops solutions for antigen-specific immune tolerance. It focuses on applying its antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and treat autoimmune diseases.
Anokion SA
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://anokion.com
Founded2011
Disease Focus
Development StageTechnology
STOCK CODENon Listed
AddressEPFL Innovation Park-LChemin de la Dent dOche 1ACH-1024EcublensSwitzerland
EPFL Innovation Park-LChemin de la Dent dOche 1ACH-1024
Ecublens
Switzerland
Contact Number+41 21 693 72 37
+41 21 693 72 37
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/anokion-sa” connections=”true” suffix=””]